Search

Ajay Nirula

from San Diego, CA
Age ~58
Get Report
Also known as:
Ajay Mirula, Ajay A Nurula, Ajay Nir, Ajay Birula, Aj Nir
Phone and address:
5171 Meadows Del Mar, San Diego, CA 92130
(858) 436-4906
Related to:
Rekha Nirula, 78Paul K Krijger, 86Lisa C Nirula, 56Moushami Nirula, 54Al NirBindu RaiNorma Krijger, 85Satish C Nirula, 90Peter A Krijger, 55Moushami Nirula
Connected to:
Ruchanee Niruntasukrat, 78Stephen Nirza, 32Ann B Nisa, 42Khairun Nisa, 60Luisa F Nisa, 55Nielson B Nisa, 62Qammar U Nisa, 57Shafia I Nisa, 34Bella Y Nisanova, 46Jason Nisanov, 44

Ajay Nirula Phones & Addresses

  • 5171 Meadows Del Mar, San Diego, CA 92130 (858) 436-4906
  • 5354 Ruette De Mer, San Diego, CA 92130 (858) 461-0408
  • Glen Ellyn, IL
  • Westlake Village, CA
  • Scotch Plains, NJ
  • 1151 Holly Ann Pl, San Jose, CA 95120 (408) 927-7517 (408) 997-2113
  • Flemington, NJ
  • South San Francisco, CA
  • Novato, CA
  • Los Angeles, CA
  • San Francisco, CA
  • San Mateo, CA

Work

Company: Amgen 2011 to Aug 2015 Position: Executive medical director, global development

Education

School / High School: University of California At Los Angeles 1993

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 2000

Industries

Pharmaceuticals

Specialities

Rheumatology

Professional Records

Medicine Doctors

Ajay Nirula Photo 1

Dr. Ajay Nirula, Westlake Village CA - MD (Doctor of Medicine)

View page
Specialties:
Rheumatology
Address:
2210 Three Springs Dr, Westlake Village, CA 91361
Certifications:
Internal Medicine, 2000
Rheumatology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of California At Los Angeles
Graduated: 1993
Ajay Nirula Photo 2

Ajay Nirula

View page
Specialties:
Internal Medicine
Rheumatology
Education:
University of California at Los Angeles (1997)

Resumes

Resumes

Ajay Nirula Photo 3

Vice President

View page
Location:
5171 Mdw, Del Mar, CA
Industry:
Pharmaceuticals
Work:
Amgen 2011 - Aug 2015
Executive Medical Director, Global Development
Eli Lilly and Company 2011 - Aug 2015
Vice President
Biogen Oct 2007 - May 2011
Senior Director, Medical Research
Merck 2005 - 2007
Associate Director
Ucsf 2002 - 2005
Adjunct Assistant Professor
Education:
University of California, Berkeley 2012 - 2014
Bachelors, Bachelor of Arts University of California, San Francisco - School of Medicine 2000 - 2005
Doctor of Medicine, Doctorates David Geffen School of Medicine at Ucla 1988 - 1997
Doctor of Medicine, Doctorates, Medicine University of California, Los Angeles 1988 - 1997
Doctor of Medicine, Doctorates, Medicine Ut Southwestern Medical Center 1991 - 1995
Doctorates, Doctor of Philosophy University of California, Berkeley 1984 - 1988
Bachelors, Bachelor of Arts University of California, Berkeley 1975 - 1979
Bachelors, Bachelor of Arts University of California, San Francisco
Languages:
English
French

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ajay Nirula
Ajay Nirula MD,PHD
Internist
5200 Illumina Way, San Diego, CA 92122
(858) 401-5181

Publications

Us Patents

Pharmaceutical Compositions Containing Dimethyl Fumarate

View page
US Patent:
20130295169, Nov 7, 2013
Filed:
Mar 14, 2013
Appl. No.:
13/827228
Inventors:
Biogen Idec MA Inc. - , US
Katherine Dawson - Westwood MA, US
Ajay Nirula - Westlake Village CA, US
International Classification:
A61K 31/225
A61K 9/48
A61K 31/616
A61K 9/20
US Classification:
424451, 514547, 424465, 424489, 514163
Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Pharmaceutical Compositions Containing Dimethyl Fumarate

View page
US Patent:
20200222354, Jul 16, 2020
Filed:
Mar 23, 2020
Appl. No.:
16/826938
Inventors:
- Cambridge MA, US
Katherine Dawson - Westwood MA, US
Ajay Nirula - Westlake Village CA, US
Assignee:
Biogen MA Inc. - Cambridge MA
International Classification:
A61K 31/225
A61K 31/60
A61K 45/06
A61K 9/20
A61K 9/28
A61K 31/616
A61K 9/48
A61K 9/16
Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Pharmaceutical Compositions Containing Dimethyl Fumarate

View page
US Patent:
20190358190, Nov 28, 2019
Filed:
Aug 5, 2019
Appl. No.:
16/532155
Inventors:
- Cambridge MA, US
Katherine Dawson - Westwood MA, US
Ajay Nirula - Westlake Village CA, US
Assignee:
Biogen MA Inc. - Cambridge MA
International Classification:
A61K 31/225
A61K 9/28
A61K 9/20
A61K 9/48
A61K 31/60
A61K 9/16
A61K 45/06
A61K 31/616
Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Pharmaceutical Compositions Containing Dimethyl Fumarate

View page
US Patent:
20180263946, Sep 20, 2018
Filed:
May 24, 2018
Appl. No.:
15/988568
Inventors:
- Cambridge MA, US
Katherine Dawson - Westwood MA, US
Ajay Nirula - Westlake Village CA, US
Assignee:
Biogen MA Inc. - Cambridge MA
International Classification:
A61K 31/225
A61K 45/06
A61K 31/60
A61K 9/28
A61K 9/20
A61K 9/48
A61K 31/616
A61K 9/16
Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Pharmaceutical Compositions Containing Dimethyl Fumarate

View page
US Patent:
20180185319, Jul 5, 2018
Filed:
Mar 2, 2018
Appl. No.:
15/910745
Inventors:
- Cambridge MA, US
Katherine Dawson - Westwood MA, US
Ajay Nirula - Westlake Village CA, US
International Classification:
A61K 31/225
A61K 45/06
A61K 31/60
A61K 9/28
A61K 9/20
A61K 9/48
A61K 9/16
A61K 31/616
Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Pharmaceutical Compositions Containing Dimethyl Fumarate

View page
US Patent:
20150209318, Jul 30, 2015
Filed:
Apr 6, 2015
Appl. No.:
14/679716
Inventors:
- Cambridge MA, US
Katherine DAWSON - Westwood MA, US
Ajay NIRULA - Westlake Village CA, US
International Classification:
A61K 31/225
A61K 31/616
A61K 9/16
A61K 9/48
A61K 9/20
A61K 9/28
Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.
Control profile
Ajay Nirula from San Diego, CA, age ~58 Get Report